Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer

Lung Cancer

Volumn 35, Issue 3, 2002, Pages 243-247

  Bozzetti, Cecilia ^a   Nizzoli, Rita ^a   Guazzi, Annamaria ^a   Franciosi, Vittorio ^a   Cattelani, Leonardo ^b   Crafa, Pellegrino ^b   Naldi, Nadia ^a   Cascinu, Stefano ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Fine needle aspiration; Immunocytochemistry; Non small cell lung cancer

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADJUVANT CHEMOTHERAPY; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELL CYCLE S PHASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOFLUOROMETRY; DNA DETERMINATION; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; TREATMENT OUTCOME;

BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DNA; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036180543     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00423-8     Document Type: Article

References (13)

1. Cancer statistics, 1994
2. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung
3. Prognostic factor analysis of 250 stage I NSCLC patients: Pathologic features are more important than molecular analyses
4. The interactive effect of Ras, HER2, p53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients
5. Multiple molecular marker testing (p53, C-Ki-ras, c-erB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
6. Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer
7. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
8. p53 mutations predict non-small cell lung carcinoma response to radiotherapy
9. Biological variables in non-small cell lung cancer: Comparison between immunocytochemical determination on fine needle aspirates from surgical specimens and immunohistochemical determination on tissue sections
10. Computed tomography-guided fine needle aspiration of peripheral lung opacities. An initial diagnostic procedure
11. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
12. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
13. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer